Pharmasset, Inc. (NASDAQ: VRUS) a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel drugs to treat viral infections is up 86.18% premarket to $135.30, relative to a 52-week range of $20.49 – $88.52.
Gilead Sciences, Inc. (NASDAQ: GILD) focuses on the development and commercialization of human therapeutics for life threatening disease is down more than 6% before market open to $37.46, relative to a 52-week range of $35.28 – 43.49.
Gilead Sciences Inc. (NASDAQ: GILD) a leading a biopharmaceutical company is planning to spend more then $11 billion to buy Pharmasset, Inc. (NASDAQ: VRUS) important things to notice here Pharmasset was valued only at $5.5 billion on Friday.
Research in Motion, Ltd. (NASDAQ: RIMM) a designer, manufacturer and marketer of wireless solutions for the worldwide mobile communications market is down 2.75% premarket to $17.69, relative to a 52-week range of $17.17 – $70.54.
Crude oil is at $96.43, down 1.29%, Gold is at $1,766, down 0.74%., Hong Kong’s Hang Seng closed down 1.44% to 18,226., Japan’s Nikkei closed lower by 0.32% to 8,348, The U.S. 10-year is at 1.95%, down 0.o6%, The FTSE is down 1.52% to $5,281, The DAX is down 2.43% to $5,660.
Latest posts by Steve Gavriliuc (see all)
- What are the 15 Most Expensive Movies Of All Time? - July 7, 2014
- Will the skyTran system change the way we travel around cities? - July 2, 2014
- 5 people who have had the courage to say no to mediocrity: Quotes - March 10, 2014